Image

Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection

Investigating TEG (a blood test that evaluates blood clotting) in Adenocarcinoma Surgical Patients

Recruiting
18-99 years
All
Phase N/A
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates adenocarcinoma. It looks at thromboelastography (TEG) parameters in patients undergoing surgery for adenocarcinoma in various organs.

The study evaluates how TEG parameters relate to disease burden and surgical outcomes. It checks if these parameters can predict complications and survival.

  • Who can participate: Adults 18 years and older with a new diagnosis of hepatopancreaticobiliary, esophageal, colorectal, or lung adenocarcinoma can participate. Individuals must not be prisoners, unable to consent, pregnant, or undergoing urgent surgery.
  • Study details: Participants will have their TEG parameters measured before and after surgery.
Print
Study details
    Liver Cancer
    Esophageal Cancer
    Colorectal Cancer
    Lung Adenocarcinoma
    Control
    Pancreas Cancer
    Biliary Cancer

NCT05517811

University of Colorado, Denver

29 August 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.